Search Results - "Mouret, E"

Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants by Gauna, F., Carof, S., Mouret‐Fourme, E., Coupier, I., Mari, V., Moretta‐Serra, J., Mancini, J., Noguès, C., Bouhnik, A. D.

“…Understanding how gender norms affect parents' communication of genetic and cancer risk information to their children can enable healthcare professionals to…”
Get full text

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response by Pierga, J.-Y, Mouret, E, Laurence, V, Diéras, V, Savigioni, A, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Pouillart, P

“…The aim of this retrospective study was to assess predictive factors for clinical response to preoperative chemotherapy and prognostic factors for survival…”
Get full text

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer by PIERGA, J-Y, MOURET, E, EXTRA, J-M, ASSELAIN, B, POUILLART, P, DIERAS, V, LAURENCE, V, BEUZEBOC, P, DORVAL, T, PALANGIE, T, JOUVE, M, VINCENT-SALOMON, A, SCHOLL, S

“…Neoadjuvant chemotherapy is able to reduce the size of the majority of breast tumours and down-stage axillary-node status. The aim of this study was to assess…”
Get full text

High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases by Zafrani, B, Aubriot, M-H, Mouret, E, De Crémoux, P, De Rycke, Y, Nicolas, A, Boudou, E, Vincent-Salomon, A, Magdelénat, H, Sastre-Garau, X

“…The hormone receptor (HR) status of breast cancer is an important prognostic factor and predictive parameter of the response to hormone therapy. Enzyme…”
Get full text

A Double-blind Randomized Trial of Wound and Intercostal Space Infiltration with Ropivacaine during Breast Cancer Surgery: Effects on Chronic Postoperative Pain by ALBI-FELDZER, Aline, MOURET-FOURME, Emmanuelle, HAMOUDA, Smail, MOTAMED, Cyrus, DUBOIS, Pierre-Yves, JOUANNEAU, Ludivine, JAYR, Christian

“…The efficacy of local anesthetic wound infiltration for the treatment of acute and chronic postoperative pain is controversial and there are no detailed…”
Get full text

Listeriosis from consumption of raw-milk cheese by Goulet, V, Jacquet, C, Vaillant, V, Rebière, I, Mouret, E, Lorente, C, Maillot, E, Staïner, F, Rocourt, J

Get more information

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database by Kaczmarek, E., Saint-Martin, C., Pierga, J.-Y., Brain, E., Rouzier, R., Savignoni, A., Mouret-Fourme, E., Dieras, V., Piot, I., Dubot, C., Carton, M., Lerebours, F.

“…Background Outcome of HER2-positive metastatic breast cancer (MBC) patients has improved since the use of trastuzumab. However, most HER2-positive MBC patients…”
Get full text

Low expression of bcl-2 in Brca1-associated breast cancers by FRENEAUX, P, STOPPA-LYONNET, D, MOURET, E, KAMBOUCHNER, M, NICOLAS, A, ZAFRANI, B, VINCENT-SALOMON, A, FOURQUET, A, MAGDELENAT, H, SASTRE-GARAU, X

“…Little data are available concerning the molecular mechanisms of action of Brca1 and Brca2 in breast oncogenesis. Recent experimental results suggest that…”
Get full text

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy by Vincent-Salomon, A., Carton, M., Freneaux, P., Palangie, T., Beuzeboc, P., Mouret, E., de Crémoux, P., Coué, O., Zafrani, B., Nicolas, A., Clough, K., Fourquet, A., Pouillart, P., Sastre-Garau, X.

“…The predictive value of ERBB2 amplification/expression to doxorubicin use is controversial. Preoperative chemotherapy, followed by the pathological assessment…”
Get full text

Isotretinoin: compliance with recommendations in childbearing women by Bensouda-Grimaldi, L, Jonville-Béra, A-P, Mouret, E, Elefant, E, Dhellot, H, Delmas, C, Gouin, T, Coste, P, Autret-Leca, E

“…The aim of this survey is to ascertain if the incidence of isotretinoin exposed pregnancies was reduced by the late recommendations of prescription and issue…”
Get full text

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer by Pierga, J.-Y, Mouret, E, Laurence, V, Diéras, V, Savigioni, A, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Pouillart, P

Get full text

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics by Julian-Reynier, Claire, Bouhnik, Anne-Déborah, Mouret-Fourme, Emanuelle, Gauthier-Villars, Marion, Berthet, Pascaline, Lasset, Christine, Fricker, Jean-Pierre, Caron, Olivier, Gesta, Paul, Luporsi, Elisabeth, Faivre, Laurence, Longy, Michel, Gladieff, Laurence, Frenay, Marc, Dreyfus, Héléne, Sobol, Hagay, Vennin, Philippe, Nogués, Catherine

“…To investigate the medical and psychosocial factors determining the time to prophylactic surgery of unaffected women carriers of a deleterious BRCA1/2…”
Get full text

Brain Metastases from Breast Cancer: Recursive Partitioning Analysis of Prognostic Factors Including Molecular Subtypes and Treatment by Le Scodan, R, Massard, C, Jouanneau, L, Coussy, F, Gutierrez, M, Kirova, Y, Labib, A, Mouret-Fourme, E

Get full text

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing by Maheu, C., Apostolidis, T., Petri-Cal, A., Mouret-Fourme, E., Gauthier-Villars, M., Lasset, C., Berthet, P., Fricker, J.-P., Caron, O., Luporsi, E., Gladieff, L., Noguès, C., Julian-Reynier, C.

“…To assess the impact of BRCA1/2 genetic test results on cancer-free women’s breast-self-examination (BSE) practices and to prospectively determine their…”
Get full text

Isotrétinoïne : suivi de l’application des recommandations des prescriptions chez les femmes en âge de procréer by Bensouda-Grimaldi, L., Jonville-Béra, A.-P., Mouret, E., Elefant, E., Dhellot, H., Delmas, C., Gouin, T., Coste, P., Autret-Leca, E., Autret-Leca, E.

“…L’objectif de ce travail est d’évaluer si l’incidence des grossesses déclarées exposées à l’isotrétinoïne [Roaccutane ®, Curacné ® Gé et Procuta ® Gé capsules]…”
Get full text

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials by Asselain, Bernard, Barlow, William, Bergh, Jonas, Bergsten-Nordström, Elizabeth, Bliss, Judith, Boccardo, Francesco, Boddington, Clare, Bogaerts, Jan, Bradley, Rosie, Brain, Etienne, Braybrooke, Jeremy, Broet, Philippe, Bryant, John, Burrett, Julie, Cameron, David, Clarke, Mike, Coates, Alan, Coleman, Robert, Coombes, Raoul Charles, Correa, Candace, Costantino, Joe, Cuzick, Jack, Davidson, Nancy, Davies, Christina, Davies, Lucy, Di Leo, Angelo, Dodwell, David, Dowsett, Mitch, Evans, Vaughan, Ewertz, Marianne, Fisher, Bernard, Forbes, John, Ford, Leslie, Gazet, Jean-Claude, Gelber, Richard, Gettins, Lucy, Gianni, Luca, Gnant, Michael, Godwin, Jon, Goldhirsch, Aron, Goodwin, Pamela, Gray, Richard, Hill, Catherine, Ingle, James, Jagsi, Reshma, Jakesz, Raimund, James, Sam, Janni, Wolfgang, Liu, Hui, Liu, Zulian, Lohrisch, Caroline, Loibl, Sibylle, Mamounas, Eleftherios, Mannu, Gurdeep, Martín, Miguel, Mathoulin, Simone, Mauriac, Louis, McGale, Paul, Morris, Philip, Mukai, Hirofumi, Norton, Larry, Ohashi, Yasuo, Olivotto, Ivo, Paik, Soon, Peto, Richard, Piccart, Martine, Pierce, Lori, Poortmans, Philip, Powles, Trevor, Pritchard, Kathy, Ragaz, Joseph, Raina, Vinod, Ravdin, Peter, Read, Simon, Regan, Meredith, Robertson, John, Rutgers, Emiel, Scholl, Suzy, Slamon, Dennis, Sölkner, Lidija, Steinberg, Seth, Sutcliffe, Rosemary, Swain, Sandra, Taylor, Carolyn, Tutt, Andrew, Valagussa, Pinuccia, van de Velde, Cornelis, van der Hage, Jos, Viale, Giuseppe, von Minckwitz, Gunter, Wang, Yaochen, Wang, Zhe, Wang, Xiang, Whelan, Tim, Wilcken, Nicholas, Winer, Eric, Wolmark, Norman, Wood, William, Zambetti, Milvia, Zujewski, Jo Anne

“…Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surgery more feasible and might be more likely to eradicate micrometastatic…”
Get full text

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants by Li, Shuai, Silvestri, Valentina, Leslie, Goska, Rebbeck, Timothy R, Neuhausen, Susan L, Hopper, John L, Nielsen, Henriette Roed, Lee, Andrew, Yang, Xin, McGuffog, Lesley, Parsons, Michael T, Andrulis, Irene L, Arnold, Norbert, Belotti, Muriel, Borg, Åke, Buecher, Bruno, Buys, Saundra S, Caputo, Sandrine M, Chung, Wendy K, Colas, Chrystelle, Colonna, Sarah V, Cook, Jackie, Daly, Mary B, de la Hoya, Miguel, de Pauw, Antoine, Delhomelle, Hélène, Eason, Jacqueline, Engel, Christoph, Evans, D Gareth, Faust, Ulrike, Fehm, Tanja N, Fostira, Florentia, Fountzilas, George, Frone, Megan, Garcia-Barberan, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Gehrig, Andrea, Glendon, Gord, Goldgar, David E, Golmard, Lisa, Greene, Mark H, Hahnen, Eric, Hamann, Ute, Hanson, Helen, Hassan, Tiara, Hentschel, Julia, Horvath, Judit, Izatt, Louise, Janavicius, Ramunas, Jiao, Yue, John, Esther M, Karlan, Beth Y, Kim, Sung-Won, Konstantopoulou, Irene, Kwong, Ava, Laugé, Anthony, Lee, Jong Won, Lesueur, Fabienne, Mebirouk, Noura, Meindl, Alfons, Mouret-Fourme, Emmanuelle, Musgrave, Hannah, Ngeow Yuen Yie, Joanne, Niederacher, Dieter, Park, Sue K, Pedersen, Inge Sokilde, Ramser, Juliane, Ramus, Susan J, Rantala, Johanna, Rashid, Muhammad U, Reichl, Florian, Ritter, Julia, Rump, Andreas, Santamariña, Marta, Saule, Claire, Schmidt, Gunnar, Schmutzler, Rita K, Senter, Leigha, Shariff, Saba, Singer, Christian F, Southey, Melissa C, Stoppa-Lyonnet, Dominique, Sutter, Christian, Tan, Yen, Teo, Soo Hwang, Terry, Mary Beth, Thomassen, Mads, Tischkowitz, Marc, Toland, Amanda E, Torres, Diana, Vega, Ana, Wagner, Sebastian A, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weber, Bernhard H F, Yannoukakos, Drakoulis, Spurdle, Amanda B, Easton, Douglas F, Chenevix-Trench, Georgia

“…To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in and for…”
Get full text

Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma by Couturier, Jérôme, Vincent-Salomon, Anne, Nicolas, André, Beuzeboc, Philippe, Mouret, Emmanuelle, Zafrani, Brigitte, Sastre-Garau, Xavier

“…ERBB2 (HER-2/neu) amplification and/or overexpression are associated with poor prognosis in node-positive breast carcinoma. Its prognostic value in…”
Get full text

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness by Patel, Vivek L, Busch, Evan L, Friebel, Tara M, Cronin, Angel, Leslie, Goska, McGuffog, Lesley, Adlard, Julian, Agata, Simona, Agnarsson, Bjarni A, Ahmed, Munaza, Aittomäki, Kristiina, Alducci, Elisa, Andrulis, Irene L, Arason, Adalgeir, Arnold, Norbert, Artioli, Grazia, Arver, Brita, Auber, Bernd, Azzollini, Jacopo, Balmaña, Judith, Barkardottir, Rosa B, Barnes, Daniel R, Barroso, Alicia, Barrowdale, Daniel, Belotti, Muriel, Benitez, Javier, Bertelsen, Birgitte, Blok, Marinus J, Bodrogi, Istvan, Bonadona, Valérie, Bonanni, Bernardo, Bondavalli, Davide, Boonen, Susanne E, Borde, Julika, Borg, Ake, Bradbury, Angela R, Brady, Angela, Brewer, Carole, Brunet, Joan, Buecher, Bruno, Buys, Saundra S, Cabezas-Camarero, Santiago, Caldés, Trinidad, Caliebe, Almuth, Caligo, Maria A, Calvello, Mariarosaria, Campbell, Ian G, Carnevali, Ileana, Carrasco, Estela, Chan, Tsun L, Chu, Annie T W, Chung, Wendy K, Claes, Kathleen B M, Collaborators, Gemo Study, Collaborators, Embrace, Cook, Jackie, Cortesi, Laura, Couch, Fergus J, Daly, Mary B, Damante, Giuseppe, Darder, Esther, Davidson, Rosemarie, de la Hoya, Miguel, Puppa, Lara Della, Dennis, Joe, Díez, Orland, Ding, Yuan Chun, Ditsch, Nina, Domchek, Susan M, Donaldson, Alan, Dworniczak, Bernd, Easton, Douglas F, Eccles, Diana M, Eeles, Rosalind A, Ehrencrona, Hans, Ejlertsen, Bent, Engel, Christoph, Evans, D Gareth, Faivre, Laurence, Faust, Ulrike, Feliubadaló, Lídia, Foretova, Lenka, Fostira, Florentia, Fountzilas, George, Frost, Debra, García-Barberán, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Géczi, Lajos, Gehrig, Andrea, Gerdes, Anne-Marie, Gesta, Paul, Giannini, Giuseppe, Glendon, Gord, Godwin, Andrew K, Goldgar, David E, Greene, Mark H, Gutierrez-Barrera, Angelica M, Hahnen, Eric, Hamann, Ute

“…Pathogenic sequence variants (PSV) in or ( ) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in were associated…”
Get full text

Abstract P5-21-14: Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: Real-life results from the Curie ESME database by Kaczmarek, E, Saint-Martin, C, Pierga, J-Y, Brain, E, Rouzier, R, Dubot, C, Savignoni, A, Mouret-Fourme, E, Simon, G, Carton, M, Lerebours, F

“…Abstract Background About 20% of breast cancer (BC) patients will develop distant metastases. HER2-positive (HER2+) disease is associated with poorer…”
Get full text